Tiaki Therapeutics Inc.
- UEI
- VVCSL43DDJB7
- CAGE
- 8HY00
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Small molecule modulation of S1PR signaling for the treatment of alzheimer's disease | National Institute on Aging (NIH) | $1,099,720 |
Quick answers
Is Tiaki Therapeutics Inc. registered in SAM.gov?
Tiaki Therapeutics Inc.'s SAM.gov registration expired on October 14, 2022.
What is Tiaki Therapeutics Inc.'s most recent federal award?
Tiaki Therapeutics Inc.'s most recent federal grant award is Small molecule modulation of S1PR signaling for the treatment of alzheimer's disease (U01AG071494), from National Institute on Aging (NIH), on September 5, 2021.
On GovTribe
See Tiaki Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors